A United States physician has been discharged from the Charité hospital in Berlin after recovering from a rare strain of the Ebola virus contracted in the Democratic Republic of Congo (DRC).

一名美國醫生在剛果民主共和國（DRC）感染了一種罕見的埃博拉病毒株，目前已在柏林的 Charité 醫院康復出院。

The patient, identified as Dr. Peter Stafford, a surgeon affiliated with the nonprofit organization Serge, was admitted to the Charité's specialized isolation unit on May 20, 2026. Diagnosis via PCR testing confirmed infection with the Bundibugyo variant, likely acquired during surgical procedures at Nyankunde Hospital. Clinical intervention consisted of a combination of supportive care and experimental antiviral therapies. This regimen resulted in a substantial reduction of viral load and the normalization of laboratory parameters; consequently, the public health authority revoked the isolation order following a period of symptom absence exceeding 72 hours and repeated negative PCR results. The patient's spouse and four children, categorized as high-risk contacts, remained asymptomatic throughout a 21-day quarantine and were discharged concurrently.

該患者為 Peter Stafford 醫生，為非營利組織 Serge 的外科醫生，於 2026 年 5 月 20 日進入 Charité 的專門隔離病房。經 PCR 檢測確認感染了 Bundibugyo 變異株，可能是在 Nyankunde 醫院執行手術過程中感染。臨床干預採取了支持性護理與實驗性抗病毒療法的組合。此方案導致病毒載量大幅下降且實驗室參數恢復正常；因此，在症狀消失超過 72 小時且 PCR 檢測反覆呈陰性後，公共衛生部門撤銷了隔離令。患者的配偶與四名子女被歸類為高風險接觸者，在 21 天的隔離期間均無症狀，並於同期出院。

Parallel to this individual recovery, the broader epidemiological situation in Central Africa remains precarious. The World Health Organization (WHO) has declared an international public health emergency, noting that the Bundibugyo strain lacks established vaccines or approved therapies. In the DRC, confirmed cases have risen to 488, with 86 fatalities, while Uganda has reported 19 cases and two deaths. Containment efforts are impeded by systemic deficiencies, including a contact tracing rate of less than 50%, laboratory backlogs, and security volatility involving armed groups. Furthermore, the response is complicated by community skepticism and targeted violence against burial teams.

與此個體康復平行的是，中非地區更廣泛的流行病學情況依然險峻。世界衛生組織（WHO）已宣布國際公共衛生緊急狀態，指出 Bundibugyo 病毒株缺乏成熟的疫苗或獲批的療法。在剛果民主共和國，確診病例已上升至 488 例，其中 86 人死亡；而烏干達則報告了 19 例病例及兩人死亡。遏制工作的進展受到系統性缺陷的阻礙，包括接觸者追蹤率低於 50%、實驗室案件積壓以及涉及武裝團體的高安全波動。此外，社區的懷疑以及針對掩埋團隊的針對性暴力，使應對工作更加複雜。

Institutional critiques, specifically from former CDC Director Tom Frieden, suggest a degradation of U.S. global health capacity. It is asserted that the current CDC is characterized by significant personnel losses and a lack of leadership stability. The withdrawal of the U.S. from the WHO and the termination of critical surveillance contracts are cited as factors that may diminish the efficacy of the international response. While the U.S. administration has outlined objectives to protect domestic health and assist the DRC, critics argue that durable security is contingent upon the immediate deployment of substantial surge support—including genomic sequencing and logistics—to the source of the outbreak.

機構批評（特別是前 CDC 局長 Tom Frieden）指出，美國的全球衛生能力有所下降。他主張目前的 CDC 具有明顯的人員流失與領導層不穩定特徵。美國退出 WHO 以及終止關鍵的監測合同，被視為可能降低國際應對效能的因素。儘管美國政府概述了保護國內健康及援助剛果民主共和國的目標，但批評者認為，持久的安全取決於是否能立即向疫情爆發源頭部署大規模的增援支持——包括基因組定序與物流支援。

While the successful treatment of Dr. Stafford demonstrates the efficacy of specialized isolation infrastructure, the regional outbreak in the DRC and Uganda continues to expand due to systemic and security constraints.

雖然成功治療 Stafford 醫生證明了專門隔離基礎設施的效能，但由於系統與安全限制，剛果民主共和國與烏干達地區的爆發情況仍持續擴大。